Impact Factor
3.39
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.52
290 total citations
h5-index
23
h5 depth signal
Cited share
58.0%
40 of 69
Total citations
290
Citation footprint
Metric signal
4.78
External metric anchor
Self-citation
3.8%
11 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
279
Italy
72
India
49
China
40
United Kingdom
22
Citing Fields of Research
Oncology
221
Immunology
86
Lymphomas
69
Lung Cancer
65
Breast Cancer
58
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,095
Articles tracked across the journal lifetime
Indexed publication set
69
40 cited publications
Last 12 months
84
7.0 publications/month
Open access share
15.5%
13 OA publications in the last year
Leading citing country
United States
279 citing publications
Leading citing field
Oncology
221 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v4n1,Mar. 1977-
v4n1,Mar. 1977-
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Immunology
Noncoding RNA
Cancer, Autophagy & Apoptosis
Cancer & Development
Prostate Cancer
Broad Categories
Neoplasms
Immunology
DNA Damage
Liver & Colon Cancer
Breast Cancer
Lung Cancer
Digestive Disorders
MeSH Descriptors
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.seminoncol.2026.152568
Open DOI
Immunotherapy in Multiple Myeloma: Molecular Mechanisms, Current Clinical Strategies, Resistance, and Future Perspectives
02
03
DOI 10.1016/j.seminoncol.2026.152566
Open DOI
Refining MRI-guided surgical strategy for borderline low rectal cancer: Beyond baseline imaging and oncologic endpoints
04
DOI 10.1016/j.seminoncol.2026.152563
Open DOI
Oncolytic viruses in gastrointestinal malignancies: Clinical progress, translational challenges, and future directions
05
DOI 10.1016/j.seminoncol.2026.152565
Open DOI
Bone metastasis in cancer: from microenvironmental remodeling to precision therapy
06
DOI 10.1016/j.seminoncol.2026.152564
Open DOI
Microbiome oncolytic virus interactions in cancer: emerging evidence and therapeutic implications for immunotherapy
07
DOI 10.1016/j.seminoncol.2026.152558
Open DOI
Dual Alexithymia: A Relational Framework for Clinical Communication in Oncology
08
DOI 10.1016/j.seminoncol.2026.152559
Open DOI
Rhabdomyolysis Resulting from the Interaction of Rosuvastatin and Abiraterone: A Case Study.
09
DOI 10.1016/j.seminoncol.2026.152562
Open DOI
NK3 Subsets Are Linked to NK Cell Exhaustion and Immunotherapy Responsiveness in Tumor
10
Bibliographical & Catalog Notes
Place of publication varies.
Also issued online.
Vol. 22, no. 1 (FEB 1995)19950520 Notice not published Printed on acid-free paper